News SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Real-time Estimate Cboe BZX Other stock markets 17:09:04 10/05/2024 BST			5-day change	1st Jan Change
0.392 ^USD	-9.03%		-13.00%	-11.84%

04-30	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	CI
04-16	SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	04-30	AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	04-30	CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	04-28	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	04-20	PR
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update	04-17	AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	04-12	PR
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference	04-11	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	04-04	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	03-28	PR
SeaStar Medical : Non-Reliance on Previously Issued Financial Report - Form 8-K	03-27	PU
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17	03-27	AQ
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	03-12	AQ
Seastar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	03-12	CI
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024	03-11	AQ
SeaStar Medical : Investor Presentation March	03-01	PU
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure	02-27	AQ
SeaStar Medical Receives FDA Approval for Pediatric Kidney Treatment Device	02-22	MT
SeaStar Medical Shares Rise 10% After FDA Humanitarian Device Exemption Approval	02-22	DJ
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury	02-22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Summary

Filters